Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of 64Cu-FAPI-XT117 PET/CT in Patients With Malignant Solid Tumors

NCT05930457 is registered in ClinicalTrials.gov with The First Affiliated Hospital of Guangzhou Medical University as lead sponsor.

NCT NCT05930457
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05930457 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of 64Cu-FAPI-XT117 PET/CT in Patients With Malignant Solid Tumors
Lead sponsor
The First Affiliated Hospital of Guangzhou Medical University
Phase
Phase 1
Overall status
Completed
Start date
July 26, 2023
Completion date
December 18, 2023
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malignant solid tumors